Dialysis News and Research

Latest Dialysis News and Research

Spectra Laboratories replaces legacy system with McKesson’s Horizon Lab LIS to improve workflow

Spectra Laboratories East (Rockleigh, N.J.), a lab division of Fresenius Medical Care North America, recently replaced its legacy system with McKesson’s Horizon Lab™ laboratory information system (LIS) to improve workflow associated with more than 30 million tests it performs annually.

16 Feb 2010

Life-sustaining interventions: Hospitals 'moving toward the middle'

Patients admitted to hospitals with higher-intensity end-of-life care live longer than those admitted to hospitals with low-intensity approaches, according to a University of Pittsburgh study available online and published in the February issue of the journal Medical Care. Higher-intensity care refers to greater use of life-sustaining measures such as ICU admission, intubation or mechanical ventilation, kidney dialysis and feeding tubes.

12 Feb 2010

Study shows benefits of stent grafts over balloon angioplasty for patients who undergo dialysis

A randomized multicenter study of 190 patients at 13 medical centers shows-- for the first time-- the "superior" benefit of stent grafts over balloon angioplasty for maintaining function of dialysis access grafts in kidney failure patients who undergo dialysis. Until now, no other therapy has proven more effective than angioplasty.

12 Feb 2010

Bard FLAIR Endovascular Stent Graft more effective than balloon angioplasty for failing dialysis grafts

C. R. Bard, Inc. today announced the publication of trial results by The New England Journal of Medicine (NEJM) showing the Bard FLAIR® Endovascular Stent Graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone. The FLAIR® Endovascular Stent Graft is the only implant approved by the U.S. Food and Drug Administration for use in the treatment of stenoses at the venous anastomosis of ePTFE or other synthetic arteriovenous access grafts.

11 Feb 2010

DPC lauds passage of S.B. 316 dialysis care legislation

Dialysis Patient Citizens today praised the Senate Insurance and Labor Committee for unanimously passing legislation – S.B. 316 – which will increase patient access to life-saving dialysis care or transplant medications. Dialysis patients attending yesterday’s hearing encouraged lawmakers to support the bill which, if enacted, would greatly help approximately 2,000 Georgians suffering from kidney failure who are having difficulty accessing health insurance. Twenty-nine states across the country have enacted this popular legislation that is widely embraced by patients, family members and taxpayers.

11 Feb 2010

Preliminary study results of ExThera Medical's Seraph extracorporeal affinity therapy published

ExThera Medical announced today that the results of a preliminary study (“Cytokines in blood from septic patients interact with surface immobilized heparin”) of its proprietary medical device, Seraph™ extracorporeal affinity therapy, have been published in the current issue of the Journal of the American Society for Artificial Organs (Jan.-Feb. 2010).

9 Feb 2010

3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.

8 Feb 2010

Kidney care advocates urge passage of key legislation for Georgia’s kidney patients

On Tuesday, February 9, kidney patients from across the state of Georgia will join Dialysis Patient Citizens (DPC) – a national, non-profit, patient-led organization representing approximately 1,300 members in Georgia and 22,000 members nationwide – in holding a briefing at the State Capitol, followed by a series of meetings with lawmakers and staff, urging the passage of key legislation this year that would help thousands of Georgia’s kidney failure patients who are struggling to access health insurance for the medical care they need.

6 Feb 2010

Valentine's Day designated as National Organ Donor Day, drive for registration

While many commemorate Valentine's Day with cards, candy and flowers, Pennsylvanians are encouraged to give the ultimate gift of love by signing up to become organ and tissue donors. With the support of the U.S. Department of Health and Human Services, Valentine's Day has been designated as National Organ Donor Day to raise awareness of the lives that can be touched -- potentially more than 50 at a time --through one person becoming an organ and tissue donor.

6 Feb 2010

Clinic closure leaves indigent dialysis patients looking for treatment

A clinic closure in Atlanta has patients and clinic officials struggling to find new providers that will treat low-income patients who need kidney dialysis, The Associated Press reports.

4 Feb 2010

Paracetamol reduces damage caused to kidneys following severe muscle injury

The commonly-used painkiller Paracetamol can protect against kidney failure after severe muscle injury, according to research at the University of Essex.

4 Feb 2010

Patients with high levels of proteinuria have increased risk of all-cause death

Patients with high levels of proteinuria (protein in urine) in addition to another marker of reduced kidney function had an associated increased risk of all-cause death, heart attack or progression to kidney failure, according to a study in the February 3 issue of JAMA.

3 Feb 2010

FMCNA ships dialysis machines and supplies for Haiti relief efforts

Fresenius Medical Care North America (FMCNA), the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, is donating and delivering dialysis supplies to Haitians, at a time when relief supplies continue to be slow to reach those in need following a devastating earthquake and aftershock.

30 Jan 2010

SCI indicates increased risk of declining kidney function in type 2 diabetics

In patients with type 2 diabetes, silent cerebral infarction (SCI)—small areas of brain damage caused by injury to small blood vessels—signals an increased risk of progressive kidney disease and kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

29 Jan 2010

Baxter International reports net income of $572M for the fourth-quarter of 2009

Baxter International Inc. today reported strong performance for the fourth quarter of 2009, and provided its financial outlook for the first quarter and full-year 2010.

From Baxter International Inc. 28 Jan 2010

Depression raises risks of advanced and severe complications from diabetes

Depression raises risks of advanced and severe complications from diabetes, according to a prospective study of Group Health primary-care patients in western Washington. These complications include kidney failure or blindness, the result of small vessel damage, as well as major vessel problems leading to heart attack or stroke.

28 Jan 2010

Investigators identify new disease mechanism and therapeutic approach for lupus kidney disease

Investigators have identified a new disease mechanism and therapeutic approach for a type of advanced kidney disease that is a common cause of complications in patients with lupus. The

27 Jan 2010

State news: New York Governor wants regulation on Rx gifts to doctors and other state news

The Associated Press/CNBC reports that New York Gov. David Paterson is "proposing new, tougher prohibitions on pharmaceutical companies, restricting them from dispensing gifts and misleading production information to doctors while promoting the use of specific drugs."

27 Jan 2010

UCSB research: Rapamycin drug, a potential treatment for ADPKD

Research performed at UC Santa Barbara points to the drug rapamycin as a potential treatment for kidney disease. The study builds on past research and shows that studies performed on mice are more likely to translate to humans than previously thought.

27 Jan 2010

Gambro acquires CHF Solutions

Gambro and CHF Solutions, Inc. (CHF) announced today that Gambro has acquired CHF, a medical device company that manufactures and distributes ultrafiltration devices to treat fluid overload.

20 Jan 2010

Dialysis News and Research

Latest Dialysis News and Research

Spectra Laboratories replaces legacy system with McKesson’s Horizon Lab LIS to improve workflow

Life-sustaining interventions: Hospitals 'moving toward the middle'

Study shows benefits of stent grafts over balloon angioplasty for patients who undergo dialysis

Bard FLAIR Endovascular Stent Graft more effective than balloon angioplasty for failing dialysis grafts

DPC lauds passage of S.B. 316 dialysis care legislation

Preliminary study results of ExThera Medical's Seraph extracorporeal affinity therapy published

3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience

Kidney care advocates urge passage of key legislation for Georgia’s kidney patients

Valentine's Day designated as National Organ Donor Day, drive for registration

Clinic closure leaves indigent dialysis patients looking for treatment

Paracetamol reduces damage caused to kidneys following severe muscle injury

Patients with high levels of proteinuria have increased risk of all-cause death

FMCNA ships dialysis machines and supplies for Haiti relief efforts

SCI indicates increased risk of declining kidney function in type 2 diabetics

Baxter International reports net income of $572M for the fourth-quarter of 2009

Depression raises risks of advanced and severe complications from diabetes

Investigators identify new disease mechanism and therapeutic approach for lupus kidney disease

State news: New York Governor wants regulation on Rx gifts to doctors and other state news

UCSB research: Rapamycin drug, a potential treatment for ADPKD

Gambro acquires CHF Solutions

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Dialysis News and Research

Latest Dialysis News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in